Dr. David Avigan from Beth-Israel Deaconess Medical Center joins us to talk about the different categories of vaccinations, the role of vaccinations post-transplant, and the future role of vaccines in myeloma treatment. Come with your questions!
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
David Avigan, MD is Chief of Division of Hematology and Hematologic Malignancies at the Beth Israel Deaconess Medical Center in Boston, Massachusetts, and is a Professor of Medicine at Harvard Medical School. Dr. Avigan's clinical interests include multiple myeloma, lymphoma, leukemia, cellular therapy, CAR T-cell therapy, immunotherapy, and all bone marrow transplant services. His board certifications include the American Board of Internal Medicine, the American Board of Internal Medicine (Hematology), and the American Board of Internal Medicine (Medical Oncology). Dr. Avigan graduated from the Yale University School of Medicine, completed his residency at Columbia Presbyterian Medical Center, and a fellowship at the Memorial Sloan-Kettering Cancer Center. Dr. Avigan is fluent in English, Hebrew and Spanish.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.